AQEMIA, a leading company in generative-AI-driven drug discovery, announces the achievement of a research milestone in its collaboration with Servier, an international independent pharmaceutical...
Zephyr AI, Inc. a healthcare technology company committed to developing fast and explainable artificial intelligence (AI) solutions to democratize precision medicine, announced the appointment...
AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last year, the...